PLA2R1 and idiopathic membranous glomerulonephritis: The M-type phospholipase A2 receptor (PLA2R) has been identified as a target antigen in approximately 70% of patients with idiopathic membranous nephropathy (IMN), and the titer of serum antibody to PLA2R (anti-PLA2R) is correlated with disease progression.